Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Regeneron Pharmaceuticals 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 USA

P: 914-847-7000

Description:

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.

Key Statistics

Overview:

Market Capitalization, $K 69,187,776
Shares Outstanding, K 107,543
Annual Sales, $ 8,497 M
Annual Net Income, $ 3,513 M
Last Quarter Sales, $ 3,453 M
Last Quarter Net Income, $ 1,632 M
60-Month Beta 0.19
% of Insider Shareholders 11.84%
% of Institutional Shareholders 82.08%
Float, K 94,810
% Float 88.16%

Growth:

1-Year Return 26.57%
3-Year Return 75.95%
5-Year Return 72.61%
5-Year Revenue Growth 107.06%
5-Year Earnings Growth 249.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 15.37 on 11/04/21
Next Earnings Date N/A
Earnings Per Share ttm 62.15
EPS Growth vs. Prev Qtr -45.05%
EPS Growth vs. Prev Year 100.13%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

REGN Ratios

Ratio
Price/Earnings ttm 10.43
Price/Earnings forward 20.78
Price/Earnings to Growth 1.20
Return-on-Equity % 50.38%
Return-on-Assets % 34.84%
Profit Margin % 41.35
Net Margin % -33.60
Debt/Equity 0.13
Price/Sales 8.20
Price/Cash Flow 19.41
Price/Book 4.04
Book Value/Share 160.48
Interest Coverage 67.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar